SUCLG2 and central nervous system cancer: Interestingly, most of the lactyl-CoA experiments by Liu et al., were performed in U87 glioma cells (36), which could be an important difference and explain why GTPSCS/SUCLG2 knockdown in HEK293T cells in our study had no effect on lactyl-CoA or Kla levels (Fig. S7).